You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 18, Issue 4

August 2011 - 13 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Article
  • Open Access
4 Citations
750 Views
6 Pages

1 August 2011

Background: In 2007, the Government of Newfoundland and Labrador established the Commission of Inquiry on Hormone Receptor Testing to examine problems with estrogen and progesterone hormone receptor tests conducted in the province between 1997 and 20...

  • Article
  • Open Access
23 Citations
1,442 Views
11 Pages

1 August 2011

Triple-negative breast cancer (TNBC) has a poor prognosis compared to other subtypes and lacks common therapeutic targets, including HER 2 and the estrogen and progesterone receptors. The clinicopathological heterogeneity of the disease and limited t...

  • Review
  • Open Access
16 Citations
839 Views
6 Pages

A Single-Centre Chart Review Exploring the Adjusted Association between Breast Cancer Phenotype and Prognosis

  • C. Hamm,
  • M. El-Masri,
  • G. Poliquin,
  • V. Poliquin,
  • J. Mathews,
  • S. Kanjeekal,
  • Y. Alam,
  • S. Kulkarni and
  • T. Elfiki

1 August 2011

Using a retrospective chart review, we investigated the differences in survival and prognostic factors between patients with triple-negative breast cancer (tnbc) and those with non-tnbc. The review included 1018 breast cancer patients who were diagno...

  • Article
  • Open Access
33 Citations
1,256 Views
10 Pages

A Comprehensive Bone-Health Management Approach for Men with Prostate Cancer Receiving Androgen Deprivation Therapy

  • C.E. Lee,
  • W.D. Leslie,
  • P. Czaykowski,
  • J. Gingerich,
  • M. Geirnaert and
  • Y.K.J. Lau

1 August 2011

For advanced and metastatic prostate cancer, androgen deprivation therapy (adt) is the mainstay of treatment. Awareness of the potential bone-health complications consequent to adt use is increasing. Many studies have shown that prolonged adt leads t...

  • Article
  • Open Access
66 Citations
1,790 Views
7 Pages

1 August 2011

Morphologic features of tumour cells have long been validated for the clinical classification of breast cancers and are regularly used as a “gold standard” to ascertain prognostic outcome in patients. Identification of molecular markers such as expre...

  • Article
  • Open Access
23 Citations
1,108 Views
5 Pages

Canadian Expert Group Consensus Recommendations: KRAS Testing in Colorectal Cancer

  • F. Aubin,
  • S. Gill,
  • R. Burkes,
  • B. Colwell,
  • S. Kamel–Reid,
  • S. Koski,
  • A. Pollett,
  • B. Samson,
  • M. Tehfe and
  • R. Wong
  • + 2 authors

1 August 2011

Monoclonal antibodies against the epidermal growth factor receptor (anti-egfr) when used in the treatment of metastatic colorectal cancer are associated with improved survival. Patients whose tumours harbor a KRAS mutation in codon 12 or 13 have been...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729